+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antipsychotic Drug"

From
From
LYBALVI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYBALVI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
LATUDA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LATUDA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
REAGILA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REAGILA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Japan, United States Japan, United States
From
From
From
Psychosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Psychosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
From
From
Neuroleptic Malignant Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Neuroleptic Malignant Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth. The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more